SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-096626
Filing Date
2022-09-01
Accepted
2022-08-31 18:45:06
Documents
2
Group Members
MARK ANGELOYA GLOBAL INVESTMENTS II (U.S.), LPYA II GP, LPYAII GP II, LLCYORKVILLE ADVISORS GLOBAL II, LLCYORKVILLE ADVISORS GLOBAL, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2224943d1_sc13g.htm SC 13G 131086
2 EXHIBIT 99.1 tm2224943d1_ex99-1.htm EX-99.1 10664
  Complete submission text file 0001104659-22-096626.txt   143628
Mailing Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302 201 985 8300
YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

IRS No.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 623 17TH STREET, SUITE 4 VERO BEACH FL 32960
Business Address 623 17TH STREET, SUITE 4 VERO BEACH FL 32960 612-961-5656
Nascent Biotech Inc. (Subject) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-92600 | Film No.: 221219123
SIC: 2834 Pharmaceutical Preparations